Medical/Pharmaceuticals
Innovent Announces an Out-license Agreement with PT Etana Biotechnologies Indonesia to Launch BYVASDA® (Bevacizumab Biosimilar) in Indonesia
SAN FRANCISCO and SUZHOU, China, Jan. 19, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-01-19 08:00
6969
Oncologist Herbert Loong Joins George Clinical Scientific Leadership
OVERLAND PARK, Kansas, Jan. 18, 2021 /PRNewswire/ -- Herbert Loong, MBBS, PDipMDPath, MRCP (UK), FRCP Edin, FHKCP, FHKAM (Medicine), an oncologist and clinical researcher based inHong Kong, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research ...
2021-01-18 23:00
2979
Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs
* Rolontis and Oraxol BLA/NDA approval from U.S. FDA is expected within this year * LAPSTriple Agonist, an innovative triple-acting new drug for NASH treatment, indication expansion * Efpeglenatide met the primary endpoint for global Phase 3 * Striving for developing rare diseases such as...
2021-01-18 22:00
2411
Regent Pacific Group Limited Announces the Successful Launch of Fortacin(TM) in Hong Kong, Upcoming Launches in Taiwan and Macau and Related Business Updates
HONG KONG, Jan. 18, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Fortacin™, the Group's ...
2021-01-18 21:21
10624
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
BEDMINSTER, N.J. and SINGAPORE, Jan. 18, 2021 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced that the European Medicines Agency (EMA) has granted PRior...
2021-01-18 19:00
1792
Everest Medicines Announces Amended Agreement with Spero Therapeutics
SHANGHAI, Jan. 18, 2021 /PRNewswire/ -- Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts ofAsia, today announced that under an amen...
2021-01-18 18:05
6260
StarMed Specialist Centre partners Prudential on the PRUPanel Connect Programme to deliver quality private healthcare experience for patients
SINGAPORE, Jan. 18, 2021 /PRNewswire/ -- StarMed Specialist Centre ("StarMed"), a private ambulatory care service provider under the HMI Group, has entered into a partnership with Prudential Singapore ("Prudential") as a preferred specialist healthcare and day surgery partner on the insurer's PRU...
2021-01-18 08:00
2661
Modern Chinese Medicine Group Co., Ltd. Trading Debut Closed at HK$1.26 Per Share
HONG KONG, Jan. 15, 2021 /PRNewswire/ -- Modern Chinese Medicine Group Co., Ltd. ("Modern Chinese Medicine", together with its subsidiaries, the "Group"; stock code: 1643), which principally engages in the production of proprietary Chinese medicine (the "PCM") and offers both over-the-counter (the...
2021-01-15 18:57
12940
Hyde Engineering + Consulting Announces Appointment of Chief Executive Officer
Kerren Bergman Promoted to Lead Hyde's Global Corporation BOULDER, Colo., Jan. 15, 2021 /PRNewswire/ -- Hyde Engineering + Consulting, Inc. (Hyde) a worldwide partner for solution-based pharmaceutical design and consulting services, announced the appointment of Kerren Bergman as Chief Executive ...
2021-01-15 00:48
14103
Nonin Medical Announces New Full Board of Directors
MINNEAPOLIS, Jan. 14, 2021 /PRNewswire/ -- Nonin Medical announced the appointment of four new members to the company's board of directors. Each of the new directors brings unique industry experience and passion for innovation in the medtech and healthcare sectors. Together, they will provide Non...
2021-01-14 21:51
2926
Modern Chinese Medicine Group Co., Ltd. announces its subscription results
HONG KONG, Jan. 14, 2021 /PRNewswire/ -- Modern Chinese Medicine Group Co., Ltd. ("Modern Chinese Medicine", together with its subsidiaries, the "Group"; stock code: 1643), which principally engages in the production of proprietary Chinese medicine (the "PCM") and offers both over-the-counter (the...
2021-01-14 14:30
10128
Ascentage Pharma Presents Updates on its Global Clinical Development at the J.P. Morgan 39th Annual Healthcare Conference
SUZHOU, China and ROCKVILLE, Md., Jan. 14, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, presented at the J.P. Morgan 39th Annual Hea...
2021-01-14 09:32
2621
RapidAI Receives 2020 Global Company of the Year Award From Frost & Sullivan for its AI-Powered Stroke Imaging and Diagnosis Technologies
RapidAI's products empower physicians with accurate information to make the right decision at the right time, leading to improved patient outcomes SANTA CLARA, Calif., Jan. 13, 2021 /PRNewswire/ -- Based on its recent analysis of the global AI-based stroke imaging and diagnosis market, Frost & ...
2021-01-13 23:21
1723
Butterfly Network and Access Afya Recognized by the World Bank Group-CES Global Tech Challenge for Work Around Solving for Accessible, Affordable Healthcare through Innovative Telehealth Model in Kenya
GUILFORD, Conn., Jan. 13, 2021 /PRNewswire/ -- Butterfly Network, Inc., an innovative digital health company that is working to enable universal access to superior medical imaging, is proud to partner with Access Afya in advancing health care on the ground inKenya, facilitated by TechEmerge He...
2021-01-13 21:22
5762
Caliber Ophthalmics Opens New State-of-the-Art Ophthalmology Center of Excellence
SINKING SPRING, Pa., Jan. 13, 2021 /PRNewswire/ -- Caliber Ophthalmics, a Surgical Specialties Corporation company, is pleased to announce the opening of a state of the art ophthalmology design and manufacturingCenter of Excellence in Sinking Spring, PA. The newly renovated 23,000 square foot faci...
2021-01-13 21:07
3080
The Sigourney Award-2020 Honors Four Recipients With Distinguished Independent Prize for Advancing Psychoanalysis and Psychoanalytic Thought
SEATTLE, Jan. 13, 2021 /PRNewswire/ -- A panel of distinguished judges evaluated a record number of applications received from 13 countries for The Sigourney Award-2020 and have selected four winners. Today,William A. Myerson, Ph.D., MBA, and psychoanalyst co-trustee ofThe Sigourney Trust, ann...
2021-01-13 21:00
1544
Mentice to enhance its organization with several new key positions
STOCKHOLM, Jan. 13, 2021 /PRNewswire/ -- Mentice AB (publ), a leading supplier of high-tech solutions for simulation in the medical sector, with focus on endovascular procedures, has announced changes to its organization. Several new key positions have been created, aimed at improving Mentice's r...
2021-01-13 20:19
1147
Holmusk, National Healthcare Group and Institute of Mental Health outline strategic collaboration to strengthen mental healthcare in Singapore
SINGAPORE, Jan. 13, 2021 /PRNewswire/ -- Holmusk has signed a Memorandum of Understanding (MOU) withSingapore's National Healthcare Group (NHG) and the Institute of Mental Health (IMH), to jointly develop innovative solutions for mental healthcare. The MOU outlines a shared vision to use digital ...
2021-01-13 14:43
2957
Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine)
SEOUL, South Korea, Jan. 13, 2021 /PRNewswire/ -- Hanmi Pharmaceutical Co., Ltd., announced "endless challenges and new commitments for the pharmaceutical industry" as their management slogan for the new year, presenting the business direction for the year 2021 at the 39th JP Morgan Healthcare...
2021-01-13 09:00
2453
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab injection) as First-Line Therapy in Hepatocellular Carcinoma (HCC)
SAN FRANCISCO and SUZHOU, China, Jan. 13, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-01-13 08:00
6029
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8546
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7700